Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.
Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
Neuro Endocrinol Lett. 2011;32(2):133-40.
Related citations
An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.
Maes M.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):784-94. doi: 10.1016/j.pnpbp.2010.06.023. Epub 2010 Jul 4. Review.
Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.
Neuro Endocrinol Lett. 2009;30(6):715-22.
Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
Maes M, Twisk FN, Ringel K.
Psychother Psychosom. 2012;81(5):286-95. doi: 10.1159/000336803. Epub 2012 Jul 20.
Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
Maes M, Twisk FN.
Neuro Endocrinol Lett. 2009;30(6):677-93. Review.
Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
Neuro Endocrinol Lett. 2009;30(4):470-6.
Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Maes M, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
Med Sci Monit. 2011 Apr;17(4):SC11-5.
IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.
Maes M, Mihaylova I, Kubera M, Leunis JC, Twisk FN, Geffard M.
Metab Brain Dis. 2012 Dec;27(4):415-23. doi: 10.1007/s11011-012-9316-8. Epub 2012 May 22.
Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease.
J Affect Disord. 2010 Sep;125(1-3):287-94. doi: 10.1016/j.jad.2009.12.014. Epub 2010 Jan 18.
Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.
BMC Med. 2010 Jun 15;8:35. doi: 10.1186/1741-7015-8-35. Review.
Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
Maes M, Twisk FN, Kubera M, Ringel K.
J Affect Disord. 2012 Feb;136(3):933-9. doi: 10.1016/j.jad.2011.09.004. Epub 2011 Oct 4.
Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression.
Maes M, Mihaylova I, Leunis JC.
Neuro Endocrinol Lett. 2007 Dec;28(6):861-7.
Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.
Neuro Endocrinol Lett. 2009;30(4):462-9.
Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.
Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):769-83. doi: 10.1016/j.pnpbp.2010.06.008. Epub 2010 Jun 16. Review.
Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
Maes M, Twisk FN, Johnson C.
Psychiatry Res. 2012 Dec 30;200(2-3):754-60. doi: 10.1016/j.psychres.2012.03.031. Epub 2012 Apr 21.
Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.
Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J.
Neuro Endocrinol Lett. 2011;32(1):7-24. Review.
IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology.
Maes M, Mihaylova I, Kubera M, Leunis JC, Geffard M.
J Affect Disord. 2011 Dec;135(1-3):414-8. doi: 10.1016/j.jad.2011.08.023. Epub 2011 Sep 17.
Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
Raison CL, Lin JM, Reeves WC.
Brain Behav Immun. 2009 Mar;23(3):327-37. doi: 10.1016/j.bbi.2008.11.005. Epub 2008 Dec 11.
Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome.
Maes M, Mihaylova I, Kubera M, Bosmans E.
Neuro Endocrinol Lett. 2007 Aug;28(4):463-9.
Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome.
Anderson G, Maes M, Berk M.
Med Hypotheses. 2012 Jun;78(6):752-6. doi: 10.1016/j.mehy.2012.02.023. Epub 2012 Mar 23. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on